🍪 The GLP Lounge uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsInternationalUK people - is Boots ever actually in stock?? Page 4

UK people - is Boots ever actually in stock??

emma_london Thu, Apr 30, 2026 at 11:47 PM 27 replies 1,145 viewsPage 4 of 6
roxy_nash
Member
178
890
Dec 2024
Nashville, TN
May 2, 2026 at 4:57 PM#16

Clinical perspective, offered as context rather than as advice. There is a difference between no evidence and evidence of no effect, and this subject is one where the two get swapped freely in both directions.

I would rather be corrected than agreed with, if it comes to it.

Last edited: May 2, 2026 at 10:57 PM
4 2josh_phd_bmore, roxy_nash, tony_orlando and 1 other
Reply Quote Save Share Report
Dr.EndoIndy
Member
267
1,234
Oct 2024
Indianapolis, IN
May 2, 2026 at 9:46 PM#17
roxy_nash said:
There is a difference between no evidence and evidence of no effect, and this subject is one where the two get swapped freely in both directions.

This matches mine closely enough to be worth saying so out loud. Nothing to add that would improve it.

5 3LeilaHI, marcus_mpls, DeniseRN_TPA and 2 others
Reply Quote Save Share Report
claudia_zurich
Member
389
1,678
Jul 2024
Zurich, CH
May 3, 2026 at 2:34 AM#18
roxy_nash said:
There is a difference between no evidence and evidence of no effect, and this subject is one where the two get swapped freely in both directions.

Coming at roxy_nash’s question from a different direction. If two explanations both fit, the useful question is which one predicts something the other does not. That is answerable; arguing about which sounds more plausible is not.

6 4Dr.LipidDallas, alex_tucson, kevin_tulsa and 3 others
Reply Quote Save Share Report

Sigma-Aldrich — Research-Grade Standards

Certified reference materials, analytical reagents, and research-grade standards for peptide verification. Trusted by laboratories worldwide.

Shop Reference Standards
raj_cambridge
Member
489
2,123
Jun 2024
Cambridge, MA
May 3, 2026 at 7:22 AM#19

Adding the numbers, since they settle part of this. Keep the original post as written when you update it, and add the correction underneath. An edited-away mistake is invisible to the next person who makes it.

Last edited: May 3, 2026 at 8:22 AM
7 5PharmHunterJen, TomTeleRx, DoseLogDan and 4 others
Reply Quote Save Share Report
Admin
Administrator
2,456
9,812
Oct 2023
Online
May 3, 2026 at 12:10 PM#20

Moderator note: reminder that nothing in this thread is medical advice, and that clinical claims need a source.

29 2PeptideSynthNJ, Dr.KarenChen, Dr.NateNeph and 26 others
Reply Quote Save Share Report

Similar Threads

EU EMA compounding guidance — 2026 regulatory update9 replies
UK NHS GLP-1 prescribing — NICE TA875 and access guide7 replies
Australian TGA scheduling changes — peptide access 20268 replies
Canadian GLP-1 coverage — provincial formulary comparison6 replies
Purchasing GLP-1 in Mexico — legality, quality, and safety concerns6 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register